4
Changes in Ownership
Structure Therapeutics Inc. Filed Acc 0001962926-26-000005
CHIEF SCIENTIFIC OFFICER acquired 23,634 shares (option exercise)
- CHIEF SCIENTIFIC OFFICER acquired 23,634 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-06-25 | Option exercise 10b5-1 | +23,634 | $0.34 | $8,036 | 252,594 | D |
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-06-25 | Conversion 10b5-1 | −23,634 | 228,960 | D | ||
| Derivatives | |||||||
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-06-25 | Option exercise · Share Option (right to buy) 10b5-1 | −23,634 | 190,166 | D | ||
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-06-25 | Conversion · American Depositary Shares 10b5-1 | +7,878 | 7,878 | D | ||
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-06-25 | Sale · American Depositary Shares 10b5-1 | −7,878 | $49.08 | $386,646 | 0 | D |
Loading xslF345X06/form4-06302026_120631.xml…